Bridging the gap between efficacy trials and model-based impact evaluation for new tuberculosis vaccines

One measurement of tuberculosis vaccine efficacy in clinical trials is prevention of disease, but different mechanisms can underlie disease prevention. Here, the authors develop a mathematical model that allows to identify mechanisms of action of a vaccine preventing TB disease.

Saved in:
Bibliographic Details
Main Authors: Mario Tovar, Sergio Arregui, Dessislava Marinova, Carlos Martín, Joaquín Sanz, Yamir Moreno
Format: article
Language:EN
Published: Nature Portfolio 2019
Subjects:
Q
Online Access:https://doaj.org/article/a7f1b051f94340bf8236bcac2684bf3d
Tags: Add Tag
No Tags, Be the first to tag this record!